Safety and efficacy of bosutinib (SKI-606) in chronic phase Philadelphia chromosome-positive chronic myeloid leukemia patients with resistance or intolerance to imatinib (Blood (2011) 118, 17 (4567-4576))

J. E. Cortes; H. M. Kantarjian; T. H. Brümmendorf

doi:10.1182/blood-2013-08-524256

Safety and efficacy of bosutinib (SKI-606) in chronic phase Philadelphia chromosome-positive chronic myeloid leukemia patients with resistance or intolerance to imatinib (Blood (2011) 118, 17 (4567-4576))

J. E. Cortes, H. M. Kantarjian, T. H. Brümmendorf

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	2524
Number of pages	1
Journal	Blood
Volume	122
Issue number	14
DOIs	https://doi.org/10.1182/blood-2013-08-524256
State	Published - Oct 3 2013
Externally published	Yes

ASJC Scopus subject areas

Biochemistry
Immunology
Hematology
Cell Biology

Access to Document

10.1182/blood-2013-08-524256

Cite this

Safety and efficacy of bosutinib (SKI-606) in chronic phase Philadelphia chromosome-positive chronic myeloid leukemia patients with resistance or intolerance to imatinib (Blood (2011) 118, 17 (4567-4576)). / Cortes, J. E.; Kantarjian, H. M.; Brümmendorf, T. H.
In: Blood, Vol. 122, No. 14, 03.10.2013, p. 2524.

Research output: Contribution to journal › Comment/debate › peer-review

@article{317c4fee165a455488c885164918587c,

title = "Safety and efficacy of bosutinib (SKI-606) in chronic phase Philadelphia chromosome-positive chronic myeloid leukemia patients with resistance or intolerance to imatinib (Blood (2011) 118, 17 (4567-4576))",

author = "Cortes, {J. E.} and Kantarjian, {H. M.} and Br{\"u}mmendorf, {T. H.}",

year = "2013",

month = oct,

day = "3",

doi = "10.1182/blood-2013-08-524256",

language = "English (US)",

volume = "122",

pages = "2524",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "14",

}

TY - JOUR

T1 - Safety and efficacy of bosutinib (SKI-606) in chronic phase Philadelphia chromosome-positive chronic myeloid leukemia patients with resistance or intolerance to imatinib (Blood (2011) 118, 17 (4567-4576))

AU - Cortes, J. E.

AU - Kantarjian, H. M.

AU - Brümmendorf, T. H.

PY - 2013/10/3

Y1 - 2013/10/3

UR - http://www.scopus.com/inward/record.url?scp=84888032225&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84888032225&partnerID=8YFLogxK

U2 - 10.1182/blood-2013-08-524256

DO - 10.1182/blood-2013-08-524256

M3 - Comment/debate

AN - SCOPUS:84888032225

SN - 0006-4971

VL - 122

SP - 2524

JO - Blood

JF - Blood

IS - 14

ER -

Safety and efficacy of bosutinib (SKI-606) in chronic phase Philadelphia chromosome-positive chronic myeloid leukemia patients with resistance or intolerance to imatinib (Blood (2011) 118, 17 (4567-4576))

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this